Wiley Bros. Aintree Capital, LLC Bristol Myers Squibb CO Transaction History

Wiley Bros. Aintree Capital, LLC

  • $5.07 Billion
  • Q3 2024

A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 92,742 shares of BMY stock, worth $5.36 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
92,742
Previous 51,080 81.56%
Holding current value
$5.36 Million
Previous $2.12 Million 126.26%
% of portfolio
0.09%
Previous 0.09%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $1.65 Million - $2.16 Million
41,662 Added 81.56%
92,742 $4.8 Million
Q2 2024

Jul 23, 2024
BUY
$40.25 - $52.99 $1.35 Million - $1.77 Million
33,469 Added 190.05%
51,080 $2.12 Million
Q1 2024

Apr 11, 2024
BUY
$47.98 - $54.4 $365,415 - $414,310
7,616 Added 76.2%
17,611 $955,000
Q4 2023

Jan 08, 2024
BUY
$48.48 - $57.85 $128,568 - $153,418
2,652 Added 36.12%
9,995 $512,000
Q3 2023

Oct 06, 2023
SELL
$57.89 - $64.73 $25,471 - $28,481
-440 Reduced 5.65%
7,343 $426,000
Q2 2023

Jul 05, 2023
SELL
$63.71 - $70.74 $35,040 - $38,907
-550 Reduced 6.6%
7,783 $497,000
Q1 2023

Apr 05, 2023
SELL
$65.71 - $74.53 $17,084 - $19,377
-260 Reduced 3.03%
8,333 $577,000
Q4 2022

Jan 10, 2023
SELL
$68.48 - $81.09 $2,739 - $3,243
-40 Reduced 0.46%
8,593 $0
Q3 2022

Oct 11, 2022
BUY
$0.13 - $76.84 $44 - $26,432
344 Added 4.15%
8,633 $614,000
Q2 2022

Jul 06, 2022
BUY
$72.62 - $79.98 $11,546 - $12,716
159 Added 1.96%
8,289 $631,000
Q1 2022

Apr 26, 2022
BUY
$61.48 - $73.72 $50,782 - $60,892
826 Added 11.31%
8,130 $594,000
Q1 2022

Apr 11, 2022
BUY
$61.48 - $73.72 $148,412 - $177,960
2,414 Added 49.37%
7,304 $533,000
Q4 2021

Jan 12, 2022
SELL
$53.63 - $62.52 $5,363 - $6,252
-100 Reduced 2.0%
4,890 $305,000
Q3 2021

Oct 07, 2021
BUY
$59.17 - $69.31 $6,508 - $7,624
110 Added 2.25%
4,990 $295,000
Q2 2021

Jul 12, 2021
BUY
$61.91 - $67.42 $3,095 - $3,371
50 Added 1.04%
4,880 $326,000
Q1 2021

Apr 09, 2021
BUY
$59.34 - $66.74 $29,670 - $33,370
500 Added 11.55%
4,830 $305,000
Q4 2020

Jan 11, 2021
BUY
$57.74 - $65.43 $51,966 - $58,887
900 Added 26.24%
4,330 $293,000
Q3 2020

Oct 05, 2020
SELL
$57.43 - $63.64 $86,145 - $95,460
-1,500 Reduced 30.43%
3,430 $243,000
Q1 2020

Apr 03, 2020
SELL
$46.4 - $67.43 $23,200 - $33,715
-500 Reduced 9.21%
4,930 $275,000
Q4 2019

Jan 10, 2020
BUY
$49.21 - $64.19 $267,210 - $348,551
5,430 New
5,430 $349,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wiley Bros. Aintree Capital, LLC Portfolio

Follow Wiley Bros. Aintree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email